You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

Article metrics

Article menu

Download PDFPDF

XML
Emerging Technologies, Pharmacology and Therapeutics
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

 

Online download statistics by month:

Online download statistics by month: June 2020 to August 2024

AbstractFullPdf
Jun 202037737688
Jul 2020998435
Aug 2020756217
Sep 2020858019
Oct 2020635712
Nov 202032312
Dec 2020403910
Jan 2021494521
Feb 202130285
Mar 2021464613
Apr 202129267
May 2021282711
Jun 202143417
Jul 202140407
Aug 2021404010
Sep 2021353410
Oct 2021403926
Nov 2021353317
Dec 2021373216
Jan 202225264
Feb 202217165
Mar 202223188
Apr 202239387
May 2022989518
Jun 202232318
Jul 202243385
Aug 202246418
Sep 2022414011
Oct 2022474917
Nov 2022353512
Dec 2022302810
Jan 202344446
Feb 202346468
Mar 2023575811
Apr 2023313213
May 202339399
Jul 2023403510
Aug 2023282813
Sep 202333325
Oct 202348499
Nov 202355549
Dec 2023594714
Jan 202436328
Feb 202450435
Mar 2024645372
Apr 202412211919
May 2024403213
Jun 202426228
Jul 2024655510
Aug 2024413015
Total26232465703